Delivering optimal MSL performance in terms of building strong KOL relationships remains a formidable challenge as regulations and compliance requirements continue to evolve across the US and Europe. More stringent rules that govern MSL-KOL interaction are barriers that MSL directors and managers must overcome if they are to grow value in their MSL teams.
FirstWord’s latest report, MSL-KOL Engagement: Building Optimal Compliant Relationships, provides the most current insight from leading subject experts familiar with the challenges MSLs face today. Learn from their approach to tackling the issues and about the solutions they have deployed to stay ahead. Benchmark your MSL-KOL engagement strategies, policies, processes and systems against leading pharma companies.
Get insights from leading pharma companies and experts including
Table of Contents |
|
|
|
This report will benefit anyone with a professional interest in the impact of new transparency regulations, especially:
Primary research from in-depth telephone interviews with medical affairs professionals from within the pharmaceutical industry and independent consultants. Supporting secondary research, mainly from publicly-available sources of information. Contributors were selected on the basis of their knowledge, experience and expertise.
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
![]() Dossier reports present unbiased and concise analysis based on interviews with leading industry experts on important trends and challenging issues affecting the pharma industry today. |
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved